Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
SimplifiMed
AddedFeb 18, 2024
UpdatedJun 18, 2026
SimplifiMed

SimplifiMed

Closed

SimplifiMed Inc: A healthcare leader developing mobile software for enhanced doctor-patient communication.

HQ
Fremont, CA, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

SimplifiMed Inc was founded with the mission to revolutionize healthcare communication by developing mobile software that bridges the gap between doctors and patients outside of traditional appointments. The company's vision is to enhance patient care and streamline medical processes through innovative technology. SimplifiMed offers a suite of mobile applications designed to facilitate real-time communication, appointment scheduling, and remote monitoring, targeting both healthcare providers and patients to improve overall healthcare outcomes.

Notable figures affiliated with SimplifiMed include key industry experts and seasoned investors who have recognized the potential of digital health solutions. The company has achieved significant milestones, such as securing partnerships with major healthcare institutions and receiving accolades for its user-friendly interface and impactful results. SimplifiMed's contributions have led to improved patient engagement and satisfaction, positioning it as a transformative player in the healthcare technology sector.

SimplifiMed - Similar Companies

Medifies logo

Medifies

medifies.com

Medcorder logo

Medcorder

medcorder.com

DocTalk logo

DocTalk

getdoctalk.com

IM Your Doc logo

IM Your Doc

imyourdoc.com

Medici logo

Medici

Epimedica logo

Epimedica

MobileMedTek logo

MobileMedTek

GetDoctor logo

GetDoctor

getdoctor.co

Medigram logo

Medigram

medigram.com

Mediprocity logo

Mediprocity

mediprocity.com

RxVantage logo

RxVantage

rxvantage.com

ConnectMD logo

ConnectMD

Global Telemedix logo

Global Telemedix

medEchat logo

medEchat

medechat.com

Prescribe logo

Prescribe

SimplifiMed - Quick Facts

Who are SimplifiMed's competitors?

Companies similar to SimplifiMed include Medifies, Medcorder, DocTalk and IM Your Doc.

When was SimplifiMed founded?

SimplifiMed was founded in 2015.

Where is SimplifiMed's headquarters located?

SimplifiMed's headquarters is located in Fremont, CA, US.

When was SimplifiMed's last funding round?

SimplifiMed's most recent funding round was for $125k (USD) in September 2016.

How much has SimplifiMed raised to-date?

As of Sep 9, 2016, SimplifiMed has raised a total of $125k (USD).

SimplifiMed - Classification

Ownership
  • Private
Revenue
  • Transactional
Main Product
  • Medical Supplies
Tags
  • eCommerce
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software